4 stories found
Scientists have made progress in treating pancreatic cancer, one of the deadliest forms of cancer with a low survival rate, by targeting the mutated KRAS protein which drives aggressive tumor growth.
Actor Karolis Kasperavičius appeared as a guest on the show 'Šeimų virtuvė', where he cooked a favorite dish of the host, Eglė Kernagytė-Dambrauskė, describing it as a true source of protein.
An experimental drug, daraxonrasib, targeting the KRAS protein, has reportedly doubled the survival rate for pancreatic cancer patients, offering new hope for the previously fatal disease.
A new targeted therapy against RAS proteins has shown to double the survival rate for pancreatic cancer patients, marking a significant breakthrough in the treatment of the disease. RAS proteins are responsible for over 90% of pancreatic cancer cases.